What amount sold does Ala Wai Pharma, Inc. report in Form D filings?

The latest linked filings report $800K sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Ala Wai Pharma, Inc.'s most recent SEC filing?

Ala Wai Pharma, Inc.'s most recent Form D filing was on 2013-08-06.

How many investors does Ala Wai Pharma, Inc. have?

The most recent Form D filing lists 3 investor(s).

What type of securities does Ala Wai Pharma, Inc. offer?

Ala Wai Pharma, Inc.'s SEC Form D filings indicate equity offerings.

Ala Wai Pharma, Inc.

CIK: 0001583673·Pharmaceuticals·HONOLULU, HI·Corporation·Founded 2011

Reported Sold

$800,000

Total Filings

Identified Offerings

Last Filed

Aug 6, 2013

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pharmaceuticals industry

SEC EDGAR

Offering filing timeline

Aug 6, 2013Form D — New notice

Reported sold: $500,000 · Target: $750,000

Rule 506·2 investors

Aug 6, 2013Form D — New notice

Reported sold: $300,000 · Target: $300,000

Rule 506·3 investors

Fundraising Profile

Exemptions

Rule 506

Investors in latest filing

Revenue Range

No Revenues

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

$800,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Barry M. Weinman

Related Person

Appears on 2 filings

Arthur Ushijima

Related Person

Appears on 2 filings

Omar Sultan

Related Person

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Aug 6, 2013	New	$750,000	$500,000	2
Aug 6, 2013	New	$300,000	$300,000	3

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

ELLA LEROY Corp

Pharmaceuticals

Offering target: $75,000

Filed Aug 11, 2026